CoChat
Cited by 4

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Age-related effects of optineurin deficiency in the mouse eye

Su, Chien-Chia, Liu, Crystal, Adi, Vishnu, Chan, Kevin C., Tseng, Henry C. · 2024 · Vision Research

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.visres.2024.108463

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 55

  1. Ames, 2021, OPTN is a host intrinsic restriction factor against neuroinvasive HSV-1 infection, Nature Communications, 12, 5401, 10.1038/s41467-021-25642-z · DOI
  2. Anborgh, 2005, Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin, Journal of Biological Chemistry, 280, 34840, 10.1074/jbc.M504508200 · DOI · Paper page
  3. Camras, 2010, Duration of anesthesia affects intraocular pressure, but not outflow facility in mice, Current Eye Research, 35, 819, 10.3109/02713683.2010.494241 · doi:10.3109/02713683.2010.494241
  4. Chibalina, 2008, Rab8-optineurin-myosin VI: Analysis of interactions and functions in the secretory pathway, Methods in Enzymology, 438, 11, 10.1016/S0076-6879(07)38002-6 · DOI
  5. Coombs, 2006, Morphological properties of mouse retinal ganglion cells, Neuroscience, 140, 123, 10.1016/j.neuroscience.2006.02.079 · DOI · Paper page
  6. Del Bo, 2011, Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis, Journal of Neurology, Neurosurgery, and Psychiatry, 82, 1239, 10.1136/jnnp.2011.242313 · DOI
  7. del Toro, 2009, Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus, Molecular Biology of the Cell, 20, 1478, 10.1091/mbc.e08-07-0726 · DOI · Paper page
  8. Djamgoz, 1997, Neurobiology of retinal dopamine in relation to degenerative states of the tissue, Vision Research, 37, 3509, 10.1016/S0042-6989(97)00129-6 · DOI · Paper page
  9. Fecto, 2011, Making connections: Pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia, Journal of Molecular Neuroscience, 45, 663, 10.1007/s12031-011-9637-9 · DOI
  10. Fenner, 2009, Identification of polyubiquitin binding proteins involved in NF-kappaB signaling using protein arrays, Biochimica et Biophysica Acta, 1794, 1010, 10.1016/j.bbapap.2009.02.013 · DOI
  11. Gleason, 2011, Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon beta, Journal of Biological Chemistry, 286, 35663, 10.1074/jbc.M111.267567 · DOI · Paper page
  12. Gordon, 2002, The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucoma, Archives of Ophthalmology, 120, 714, 10.1001/archopht.120.6.714 · DOI · Paper page
  13. Gupta, 2007, Glaucoma as a neurodegenerative disease, Current Opinion in Ophthalmology, 18, 110, 10.1097/ICU.0b013e3280895aea · DOI · Paper page
  14. Hattula, 2000, FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis, Current Biology, 10, 1603, 10.1016/S0960-9822(00)00864-2 · DOI · Paper page
  15. Hu, 2023, Optineurin regulates osteoblast function in an age-dependent fashion in a mouse model of Paget's disease of bone, Bone, 177, 10.1016/j.bone.2023.116929 · DOI
  16. Hu, 2023, Optineurin regulates NRF2-mediated antioxidant response in a mouse model of Paget's disease of bone, Science Advances, 9, eade6998, 10.1126/sciadv.ade6998 · DOI
  17. Indrieri, 2020, Dopamine, alpha-synuclein, and mitochondrial dysfunctions in parkinsonian eyes, Frontiers in Neuroscience, 14, 10.3389/fnins.2020.567129 · DOI
  18. Jakobs, 2005, Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice, Journal of Cell Biology, 171, 313, 10.1083/jcb.200506099 · DOI · Paper page
  19. Kachaner, 2012, Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progression, Molecular Cell, 45, 553, 10.1016/j.molcel.2011.12.030 · DOI
  20. Laplantine, 2009, NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain, The EMBO Journal, 28, 2885, 10.1038/emboj.2009.241 · DOI · Paper page
  21. Lin, 2013, Retinal ganglion cells are resistant to photoreceptor loss in retinal degeneration, PLoS One1, 8, e68084, 10.1371/journal.pone.0068084 · DOI
  22. Lin, 2004, Retinal ganglion cell type, size, and spacing can be specified independent of homotypic dendritic contacts, Neuron, 43, 475, 10.1016/j.neuron.2004.08.002 · DOI · Paper page
  23. Markovinovic, 2017, Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms, Progress in Neurobiology, 154, 1, 10.1016/j.pneurobio.2017.04.005 · DOI
  24. Maruyama, 2010, Mutations of optineurin in amyotrophic lateral sclerosis, Nature, 465, 223, 10.1038/nature08971 · DOI · Paper page
  25. Meng, 2012, Overexpressed mutant optineurin (E50K) induces retinal ganglion cells apoptosis via the mitochondrial pathway, Molecular Biology Reports, 39, 5867, 10.1007/s11033-011-1397-7 · DOI
  26. Minegishi, 2016, Significance of optineurin mutations in glaucoma and other diseases, Progress in Retinal and Eye Research, 55, 149, 10.1016/j.preteyeres.2016.08.002 · DOI
  27. Moreland, 2000, Identification of a transcription factor IIIA-interacting protein, Nucleic Acids Research, 28, 1986, 10.1093/nar/28.9.1986 · DOI
  28. Morton, 2008, Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma, FEBS Letters, 582, 997, 10.1016/j.febslet.2008.02.047 · DOI · Paper page
  29. Mukherjee, 2017, Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease, PLoS One1, 12, e0185242, 10.1371/journal.pone.0185242 · DOI
  30. Murphy, 1985, Anesthesia and intraocular pressure, Anesthesia & Analgesia, 64, 520, 10.1213/00000539-198505000-00013 · doi:10.1213/00000539-198505000-00013
  31. Nagabhushana, 2011, Optineurin is required for CYLD-dependent inhibition of TNFalpha-induced NF-kappaB activation, PLoS One1, 6, e17477, 10.1371/journal.pone.0017477 · DOI
  32. Nagabhushana, 2010, Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant, BMC Molecular and Cell Biology, 11, 4, 10.1186/1471-2121-11-4 · DOI
  33. Park, 2010, Impairment of protein trafficking upon overexpression and mutation of optineurin, PLoS One1, 5, e11547, 10.1371/journal.pone.0011547 · DOI
  34. Patil, 2022, Intrinsic antiviral activity of optineurin prevents hyperproliferation of a primary herpes simplex virus type 2 infection, Journal of Immunology, 208, 63, 10.4049/jimmunol.2100472 · DOI
  35. Quigley, 2006, The number of people with glaucoma worldwide in 2010 and 2020, British Journal of Ophthalmology, 90, 262, 10.1136/bjo.2005.081224 · DOI · Paper page
  36. Rezaie, 2002, Adult-onset primary open-angle glaucoma caused by mutations in optineurin, Science, 295, 1077, 10.1126/science.1066901 · DOI · Paper page
  37. Rezaie, 2005, Molecular cloning, genomic structure, and protein characterization of mouse optineurin, Genomics, 85, 131, 10.1016/j.ygeno.2004.10.011 · DOI
  38. Rezaie, 2005, Molecular cloning and expression profiling of optineurin in the rhesus monkey, Investigative Ophthalmology & Visual Science, 46, 2404, 10.1167/iovs.04-1243 · DOI
  39. Sahlender, 2005, Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis, Journal of Cell Biology, 169, 285, 10.1083/jcb.200501162 · DOI · Paper page
  40. Shen, 2015, Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism, Autophagy, 11, 685, 10.4161/auto.36098 · DOI · Paper page
  41. Shields, 2008, Normal-tension glaucoma: Is it different from primary open-angle glaucoma?, Current Opinion in Ophthalmology, 19, 85, 10.1097/ICU.0b013e3282f3919b · DOI · Paper page
  42. Sirohi, 2016, Defects in autophagy caused by glaucoma-associated mutations in optineurin, Experimental Eye Research, 144, 54, 10.1016/j.exer.2015.08.020 · DOI · Paper page
  43. Slowicka, 2016, Optineurin deficiency in mice is associated with increased sensitivity to Salmonella but does not affect proinflammatory NF-kappaB signaling, European Journal of Immunology, 46, 971, 10.1002/eji.201545863 · DOI · Paper page
  44. Sudhakar, 2009, NF-kappaB mediates tumor necrosis factor alpha-induced expression of optineurin, a negative regulator of NF-kappaB, PLoS One1, 4, e5114, 10.1371/journal.pone.0005114 · DOI
  45. Sun, 2002, Large-scale morphological survey of mouse retinal ganglion cells, The Journal of Comparative Neurology, 451, 115, 10.1002/cne.10323 · DOI · Paper page
  46. Tseng, 2015, Visual impairment in an optineurin mouse model of primary open angle glaucoma, Neurobiology of Aging, 36, 2201, 10.1016/j.neurobiolaging.2015.02.012 · DOI · Paper page
  47. Volpe, 2015, Ophthalmic manifestations of amyotrophic lateral sclerosis (An American Ophthalmological Society Thesis), Transactions of the American Ophthalmological Society, 113, T12
  48. Weinreb, 2014, The pathophysiology and treatment of glaucoma: A review, Journal of the American Medical Association, 311, 1901, 10.1001/jama.2014.3192 · DOI · Paper page
  49. Witkovsky, 2004, Dopamine and retinal function, Documenta Ophthalmologica, 108, 17, 10.1023/B:DOOP.0000019487.88486.0a · DOI · Paper page
  50. Wong, 2007, Age-related changes in visual acuity, learning and memory in C57BL/6J and DBA/2J mice, Neurobiology of Aging, 28, 1577, 10.1016/j.neurobiolaging.2006.07.023 · DOI
  51. Wong, 2015, Temporal dynamics of PARK2/parkin and OPTN/optineurin recruitment during the mitophagy of damaged mitochondria, Autophagy, 11, 422, 10.1080/15548627.2015.1009792 · DOI
  52. Xue, 2021, Deficiency of optineurin enhances osteoclast differentiation by attenuating the NRF2-mediated antioxidant response, Experimental & Molecular Medicine, 53, 667, 10.1038/s12276-021-00596-w · DOI
  53. Yamano, 2024, Optineurin provides a mitophagy contact site for TBK1 activation, The EMBO Journal, 43, 754, 10.1038/s44318-024-00036-1 · DOI
  54. Ying, 2015, Induction of autophagy in rats upon overexpression of wild-type and mutant optineurin gene, BMC Molecular and Cell Biology, 16, 14, 10.1186/s12860-015-0060-x · DOI
  55. Zhang, 2021, The E50K optineurin mutation impacts autophagy-mediated degradation of TDP-43 and leads to RGC apoptosis in vivo and in vitro, Cell Death Discovery, 7, 49, 10.1038/s41420-021-00432-0 · DOI

Cited by

See all 4

Metadata

Authors
Su, C.-C., Liu, C., Adi, V., Chan, K. C., & Tseng, H. C.
Venue
Vision Research
Publisher
Elsevier BV
Published
2024-11
Volume
224
Pages
108463
ISSN
0042-6989
Cited by
4
References
9
Language
en
Funders
  • National Eye Institute (P30-EY005722)
  • National Science and Technology Council
  • Alcon Research Institute
  • Research to Prevent Blindness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.